1 – 20 of 36
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes
(
- Contribution to journal › Article
- 2023
-
Mark
Long-term outcomes of vedolizumab in inflammatory bowel disease : the Swedish prospective multicentre SVEAH extension study
(
- Contribution to journal › Article
-
Mark
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE) : a multicentre, open-label, randomised controlled trial
(
- Contribution to journal › Article
- 2021
-
Mark
Clinical effectiveness of golimumab in ulcerative colitis : a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG
(
- Contribution to journal › Article
-
Mark
Real-world effectiveness of vedolizumab in inflammatory bowel disease : week 52 results from the Swedish prospective multicentre SVEAH study
(
- Contribution to journal › Article
-
Mark
Association Between Collagenous and Lymphocytic Colitis and Risk of Severe Coronavirus Disease 2019
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Tissue-specific transcriptional imprinting and heterogeneity in human innate lymphoid cells revealed by full-length single-cell RNA-sequencing
(
- Contribution to journal › Article
- 2020
-
Mark
Short and long-term efficacy of adalimumab in ulcerative colitis : a real-life study
(
- Contribution to journal › Article
-
Mark
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
(
- Contribution to journal › Article
- 2019
-
Mark
Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term effectiveness of vedolizumab in inflammatory bowel disease : a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
(
- Contribution to journal › Article
-
Mark
Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis.
(
- Contribution to journal › Article
- 2016
-
Mark
Pregnancy and childbirth in women with autoimmune hepatitis is safe, even in compensated cirrhosis.
(
- Contribution to journal › Article
- 2015
-
Mark
Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis - a long-term follow-up study in 634 Swedish patients
(
- Contribution to journal › Article
- 2014
-
Mark
Novel assay to improve therapeutic drug monitoring of thiopurines in inflammatory bowel disease.
(
- Contribution to journal › Article
-
Mark
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
(
- Contribution to journal › Article
- 2013
-
Mark
Moderate hyperkalemia in hospitalized patients with cirrhotic ascites indicates a poor prognosis
(
- Contribution to journal › Article
- 2011
-
Mark
The Role of Inosine-5'-Monophosphate Dehydrogenase in Thiopurine Metabolism in Patients With Inflammatory Bowel Disease.
(
- Contribution to journal › Article
-
Mark
Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population
(
- Contribution to journal › Article
- 2010
-
Mark
Increased Factor Viii Activity In Portal Vein Thrombosis And Budd-Chiari Syndrome
2010) 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases In Hepatology 52(4). p.1217-1217(
- Contribution to journal › Published meeting abstract